174 related articles for article (PubMed ID: 19614710)
1. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival.
Wang Y; Fang M; Sun X; Sun J
Int J Lab Hematol; 2010 Apr; 32(2):230-8. PubMed ID: 19614710
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
Verstovsek S; Manshouri T; Smith FO; Giles FJ; Cortes J; Estey E; Kantarjian H; Keating M; Jeha S; Albitar M
Cancer; 2003 May; 97(9):2212-7. PubMed ID: 12712473
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.
Park HS; Choi J; See CJ; Kim JA; Park SN; Im K; Kim SM; Lee DS; Hwang SM
Ann Lab Med; 2017 May; 37(3):195-203. PubMed ID: 28224765
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
6. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival.
Ghaffari SH; Shayan-Asl N; Jamialahmadi AH; Alimoghaddam K; Ghavamzadeh A
Ann Oncol; 2008 Nov; 19(11):1927-34. PubMed ID: 18567608
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of telomerase activity levels in acute leukemia.
Ohyashiki JH; Ohyashiki K; Iwama H; Hayashi S; Toyama K; Shay JW
Clin Cancer Res; 1997 Apr; 3(4):619-25. PubMed ID: 9815729
[TBL] [Abstract][Full Text] [Related]
9. Telomere length is a prognostic factor in neuroblastoma.
Ohali A; Avigad S; Ash S; Goshen Y; Luria D; Feinmesser M; Zaizov R; Yaniv I
Cancer; 2006 Sep; 107(6):1391-9. PubMed ID: 16917952
[TBL] [Abstract][Full Text] [Related]
10. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
Kubuki Y; Suzuki M; Sasaki H; Toyama T; Yamashita K; Maeda K; Ido A; Matsuoka H; Okayama A; Nakanishi T; Tsubouchi H
Leuk Lymphoma; 2005 Mar; 46(3):393-9. PubMed ID: 15621829
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in myelodysplastic syndrome.
Fu C; Chen Z
Chin Med J (Engl); 2002 Oct; 115(10):1475-8. PubMed ID: 12490090
[TBL] [Abstract][Full Text] [Related]
13. Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors.
Ohali A; Avigad S; Cohen IJ; Meller I; Kollender Y; Issakov J; Gelernter I; Goshen Y; Yaniv I; Zaizov R
J Clin Oncol; 2003 Oct; 21(20):3836-43. PubMed ID: 14551302
[TBL] [Abstract][Full Text] [Related]
14. Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia.
Verstovsek S; Kantarjian H; Manshouri T; Cortes J; Faderl S; Giles FJ; Keating M; Albitar M
Cancer; 2003 Mar; 97(5):1248-52. PubMed ID: 12599232
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity in patients with chronic myeloid leukemia and lymphoma.
Bitisik O; Yavuz S; Yasasever V; Dalay N
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):3-12. PubMed ID: 11334367
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
17. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
18. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.
Ulaner GA; Huang HY; Otero J; Zhao Z; Ben-Porat L; Satagopan JM; Gorlick R; Meyers P; Healey JH; Huvos AG; Hoffman AR; Ladanyi M
Cancer Res; 2003 Apr; 63(8):1759-63. PubMed ID: 12702558
[TBL] [Abstract][Full Text] [Related]
19. Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
Keller G; Brassat U; Braig M; Heim D; Wege H; Brümmendorf TH
Hematol Oncol; 2009 Sep; 27(3):123-9. PubMed ID: 19569255
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia.
Verstovsek S; Giles FJ; O'Brien S; Faderl S; Kantarjian HM; Keating MJ; Albitar M
Leuk Res; 2004 Jul; 28(7):707-11. PubMed ID: 15158092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]